軟部組織生物学的製剤のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

当レポートでは、軟部組織生物学的製剤のパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 軟部組織生物学的製剤 - パイプライン製品：開発段階別
• 軟部組織生物学的製剤 - パイプライン製品：セグメント別
• 軟部組織生物学的製剤 - パイプライン製品：地域別
• 軟部組織生物学的製剤 - パイプライン製品：規制経路別
• 軟部組織生物学的製剤 - パイプライン製品：推定承認日別
• 軟部組織生物学的製剤 - 進行中の臨床試験

第4章 軟部組織生物学的製剤 - 各社の開発中のパイプライン製品

• 軟部組織生物学的製剤企業 - パイプライン製品：開発段階別
• 軟部組織生物学的製剤 - パイプライン製品：開発段階別

第5章 軟部組織生物学的製剤の企業と製品の概要

• Acuitive Technologies Inc：企業の概要
  • Acuitive Technologies Inc：パイプライン製品と進行中の臨床試験の概要
• Anika Therapeutics Inc：企業の概要
  • Anika Therapeutics Inc：パイプライン製品と進行中の臨床試験の概要
• BioGend Therapeutics Co Ltd：企業の概要
  • BioGend Therapeutics Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Colorado Therapeutics, LLC：企業の概要
  • Colorado Therapeutics, LLC：パイプライン製品と進行中の臨床試験の概要
• Columbia University：企業の概要
  • Columbia University：パイプライン製品と進行中の臨床試験の概要
• Core Essence Orthopaedics, LLC：企業の概要
  • Core Essence Orthopaedics, LLC：パイプライン製品と進行中の臨床試験の概要
• Georgia Institute of Technology：企業の概要
  • Georgia Institute of Technology：パイプライン製品と進行中の臨床試験の概要
• New York R&D Center for Translational Medicine and Therapeutics Inc：企業の概要
  • New York R&D Center for Translational Medicine and Therapeutics Inc：パイプライン製品と進行中の臨床試験の概要
• Nutech Medical Inc：企業の概要
  • Nutech Medical Inc：パイプライン製品と進行中の臨床試験の概要
• OHSU Knight Cancer Institute：企業の概要
  • OHSU Knight Cancer Institute：パイプライン製品と進行中の臨床試験の概要
• Osteopore International Pte Ltd：企業の概要
  • Osteopore International Pte Ltd：パイプライン製品と進行中の臨床試験の概要
• Shandong Junxiu Biotechnology Co Ltd：企業の概要
  • Shandong Junxiu Biotechnology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• STEL Technologies LLC：企業の概要
  • STEL Technologies LLC：パイプライン製品と進行中の臨床試験の概要
• Tissue Regenix Group PLC：企業の概要
  • Tissue Regenix Group PLC：パイプライン製品と進行中の臨床試験の概要
• University of Arizona：企業の概要
  • University of Arizona：パイプライン製品と進行中の臨床試験の概要
• University of Bielefeld：企業の概要
  • University of Bielefeld：パイプライン製品と進行中の臨床試験の概要
• University of Minnesota：企業の概要
  • University of Minnesota：パイプライン製品と進行中の臨床試験の概要
• University of Missouri：企業の概要
  • University of Missouri：パイプライン製品と進行中の臨床試験の概要
• University of Zurich：企業の概要
  • University of Zurich：パイプライン製品と進行中の臨床試験の概要

第6章 軟部組織生物学的製剤 - 近年の発展

• 2024年8月27日：Chinese Academy of Sciences、3Dバイオプリンティング材料が骨と軟部組織の修復を改善する可能性をもたらす
• 2024年8月12日：Biorez、BioBrace Reinforced Implantの510（K）承認を取得
• 2024年6月11日：Allosource、股関節唇の再建と補強に用いる初の縫合済み筋膜デバイス、Aceconnexを発売
• 2024年5月2日：Organogenesis、膝関節炎治療薬ReNuのフェーズ3臨床試験で主要評価項目を達成
• 2023年11月2日：Humacyte、2023年11月9日に第3四半期の財務結果を発表し、企業の最新情報を提供
• 2023年10月31日：BioTissueの革新的なヒト羊膜同種移植が、症例研究で複雑な足の潰瘍や外傷の治療に有効であることが示される

第7章 付録

List of Tables

• Soft Tissue Biologics - Pipeline Products by Stage of Development
• Soft Tissue Biologics - Pipeline Products by Segment
• Soft Tissue Biologics - Pipeline Products by Territory
• Soft Tissue Biologics - Pipeline Products by Regulatory Path
• Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
• Soft Tissue Biologics - Ongoing Clinical Trials
• Soft Tissue Biologics Companies - Pipeline Products by Stage of Development
• Soft Tissue Biologics - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Soft Tissue Biologics - Pipeline Products by Stage of Development
• Soft Tissue Biologics - Pipeline Products by Segment
• Soft Tissue Biologics - Pipeline Products by Territory
• Soft Tissue Biologics - Pipeline Products by Regulatory Path
• Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
• Soft Tissue Biologics - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Soft Tissue Biologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Soft Tissue Biologics pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. Soft Tissue Biologics market focuses on the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles's tendon.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Soft Tissue Biologics under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Soft Tissue Biologics and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Soft Tissue Biologics under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Soft Tissue Biologics Overview

3 Products under Development

• 3.1 Soft Tissue Biologics - Pipeline Products by Stage of Development
• 3.2 Soft Tissue Biologics - Pipeline Products by Segment
• 3.3 Soft Tissue Biologics - Pipeline Products by Territory
• 3.4 Soft Tissue Biologics - Pipeline Products by Regulatory Path
• 3.5 Soft Tissue Biologics - Pipeline Products by Estimated Approval Date
• 3.6 Soft Tissue Biologics - Ongoing Clinical Trials

4 Soft Tissue Biologics - Pipeline Products under Development by Companies

• 4.1 Soft Tissue Biologics Companies - Pipeline Products by Stage of Development
• 4.2 Soft Tissue Biologics - Pipeline Products by Stage of Development

5 Soft Tissue Biologics Companies and Product Overview

• 5.1 Acuitive Technologies Inc Company Overview
  • 5.1.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Anika Therapeutics Inc Company Overview
  • 5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 BioGend Therapeutics Co Ltd Company Overview
  • 5.3.1 BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Colorado Therapeutics, LLC Company Overview
  • 5.4.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Columbia University Company Overview
  • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Core Essence Orthopaedics, LLC Company Overview
  • 5.6.1 Core Essence Orthopaedics, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Georgia Institute of Technology Company Overview
  • 5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 New York R&D Center for Translational Medicine and Therapeutics Inc Company Overview
  • 5.8.1 New York R&D Center for Translational Medicine and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Nutech Medical Inc Company Overview
  • 5.9.1 Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 OHSU Knight Cancer Institute Company Overview
  • 5.10.1 OHSU Knight Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Osteopore International Pte Ltd Company Overview
  • 5.11.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Shandong Junxiu Biotechnology Co Ltd Company Overview
  • 5.12.1 Shandong Junxiu Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 STEL Technologies LLC Company Overview
  • 5.13.1 STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Tissue Regenix Group PLC Company Overview
  • 5.14.1 Tissue Regenix Group PLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 University of Arizona Company Overview
  • 5.15.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 University of Bielefeld Company Overview
  • 5.16.1 University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 University of Minnesota Company Overview
  • 5.17.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 University of Missouri Company Overview
  • 5.18.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 University of Zurich Company Overview
  • 5.19.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview

6 Soft Tissue Biologics- Recent Developments

• 6.1 Aug 27, 2024: Chinese Academy of Sciences : 3D Bioprinting Materials Offer Possibility for Better Bone and Soft Tissue Repair
• 6.2 Aug 12, 2024: Biorez Receives 510(K) Clearance for BioBrace Reinforced Implant
• 6.3 Jun 11, 2024: Allosource Launches Aceconnex, First Pre-sutured Fascia Device for Hip Labral Reconstruction and Augmentation
• 6.4 May 02, 2024: Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
• 6.5 Nov 02, 2023: Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023
• 6.6 Oct 31, 2023: BioTissue's Innovative Human Amniotic Allografts Show Efficacy in Treating Complex Foot Ulcers and Traumatic Wounds in Case Studies

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer